DE69504808D1 - Corticotropin freisetzende rezeptoren des faktor 2 - Google Patents

Corticotropin freisetzende rezeptoren des faktor 2

Info

Publication number
DE69504808D1
DE69504808D1 DE69504808T DE69504808T DE69504808D1 DE 69504808 D1 DE69504808 D1 DE 69504808D1 DE 69504808 T DE69504808 T DE 69504808T DE 69504808 T DE69504808 T DE 69504808T DE 69504808 D1 DE69504808 D1 DE 69504808D1
Authority
DE
Germany
Prior art keywords
receptors
factor
corticotropin releasing
sub
releasing receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69504808T
Other languages
English (en)
Other versions
DE69504808T2 (de
DE69504808T3 (de
Inventor
Derek Chalmers
Timothy W Lovenberg
Tilman Oltersdorf
Chen Wang Liaw
Dimitri E Grigoriadis
Souza Errol B De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurocrine Biosciences Inc
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27401275&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69504808(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/381,433 external-priority patent/US5786203A/en
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Application granted granted Critical
Publication of DE69504808D1 publication Critical patent/DE69504808D1/de
Publication of DE69504808T2 publication Critical patent/DE69504808T2/de
Publication of DE69504808T3 publication Critical patent/DE69504808T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69504808T 1994-06-14 1995-06-14 Corticotropin freisetzende rezeptoren des faktor 2 Expired - Lifetime DE69504808T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25995994A 1994-06-14 1994-06-14
US08/381,433 US5786203A (en) 1994-06-14 1995-01-31 Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
US48598495A 1995-06-07 1995-06-07
PCT/US1995/007757 WO1995034651A2 (en) 1994-06-14 1995-06-14 Corticotropin-releasing factor2 receptors

Publications (3)

Publication Number Publication Date
DE69504808D1 true DE69504808D1 (de) 1998-10-22
DE69504808T2 DE69504808T2 (de) 1999-05-12
DE69504808T3 DE69504808T3 (de) 2002-12-12

Family

ID=27401275

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69504808T Expired - Lifetime DE69504808T3 (de) 1994-06-14 1995-06-14 Corticotropin freisetzende rezeptoren des faktor 2

Country Status (10)

Country Link
US (2) US6723841B2 (de)
EP (1) EP0724637B2 (de)
JP (1) JPH10501420A (de)
AT (1) ATE171212T1 (de)
AU (1) AU703140B2 (de)
CA (1) CA2193072A1 (de)
DE (1) DE69504808T3 (de)
DK (1) DK0724637T4 (de)
ES (1) ES2123269T5 (de)
WO (1) WO1995034651A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232329A1 (en) * 1994-06-10 2003-12-18 Jeffrey R. De Wet Novel human crh receptor-related receptor
US6214797B1 (en) 1995-06-13 2001-04-10 The Salk Institute For Biological Studies Urocortin peptides, nucleic acid encoding same methods for using same
CA2223792A1 (en) * 1995-06-13 1997-01-03 The Salk Institute For Biological Studies Urocortin peptides
WO1997020928A1 (fr) 1995-12-06 1997-06-12 Sumitomo Pharmaceuticals Company, Limited Nouvelle semaphorine z et gene la codant
UA70912C2 (uk) * 1996-02-28 2004-11-15 Cінгента Партісіпейшнс Аг Молекула днк, яка кодує стійку до дії інгібітора рослинну протопорфіриногеноксидазу, спосіб одержання стійких до гербіциду рослин, спосіб боротьби з ростом небажаних рослин
US5888811A (en) * 1996-05-23 1999-03-30 Dupont Pharmaceuticals Company Corticotropin-releasing hormone receptor
AU7935098A (en) * 1997-06-30 1999-01-19 Taisho Pharmaceutical Co., Ltd. Proteins capable of binding to corticotropin-releasing factor
AU777469B2 (en) * 1999-04-15 2004-10-21 Cambridge University Technical Services Limited A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
NZ516611A (en) * 1999-07-15 2003-09-26 Res Dev Foundation Mice that are homozygously deficient in CRFR2 and uses thereof in drug screening
US7674463B1 (en) * 1999-07-15 2010-03-09 Research Development Foundation Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist
AU6514400A (en) * 1999-08-24 2001-03-19 Regents Of The University Of California, The Method of identifying urotensin ii receptor antagonists
AU2001280632A1 (en) * 2000-07-19 2002-01-30 Bristol-Myers Squibb Pharma Company CRF2 ligands in combination therapy
JP4830079B2 (ja) * 2000-11-29 2011-12-07 国立感染症研究所長 プロテアーゼ活性の測定方法
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
WO2005103690A2 (en) * 2004-04-24 2005-11-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
CA2749041C (en) * 2008-12-31 2019-09-03 Abbott Point Of Care Inc. Method and device for immunoassay using obligonucleotide conjugates
JOP20170153A1 (ar) 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232329A1 (en) 1994-06-10 2003-12-18 Jeffrey R. De Wet Novel human crh receptor-related receptor
US5786203A (en) 1994-06-14 1998-07-28 Neurocrine Biosciences, Inc. Isolated nucleic acid encoding corticotropin-releasing factor2 receptors

Also Published As

Publication number Publication date
US6723841B2 (en) 2004-04-20
WO1995034651A3 (en) 1996-03-14
DK0724637T3 (da) 1999-06-14
DE69504808T2 (de) 1999-05-12
US7034118B2 (en) 2006-04-25
DE69504808T3 (de) 2002-12-12
US20020077468A1 (en) 2002-06-20
ES2123269T3 (es) 1999-01-01
AU703140B2 (en) 1999-03-18
EP0724637A1 (de) 1996-08-07
EP0724637B2 (de) 2002-06-05
ES2123269T5 (es) 2002-11-01
AU2945595A (en) 1996-01-05
DK0724637T4 (da) 2002-09-16
CA2193072A1 (en) 1995-12-21
ATE171212T1 (de) 1998-10-15
EP0724637B1 (de) 1998-09-16
JPH10501420A (ja) 1998-02-10
US20040185533A1 (en) 2004-09-23
WO1995034651A2 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
DE69504808D1 (de) Corticotropin freisetzende rezeptoren des faktor 2
DE69333731D1 (de) Glialmitogene faktoren, ihre herstellung und verwendung
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
BR9812540A (pt) Expressão de genes endógenos por recombinaçãonão homóloga de uma construção de vetor comdna celular
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
DE69534300D1 (de) Neues multimerisierendes reagenz
EP1135532A4 (de) Fluoreszierende proteine aus nicht-biolumineszenten arten der klasse anthozoa, gene die diese proteine kodieren und deren verwendungen
EP0804609A4 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
DE50015938D1 (de) Polypeptidvarianten mit erhoehter heparin-bindungsfaehigkeit
DE69836823D1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
WO1996007739A3 (en) Interleukin-1 type 3 receptors
FI961202A0 (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
WO1996001317A3 (en) Mammalian peroxisome proliferator-activated receptors and uses thereof
AU5559499A (en) Identification of the gene causing the mouse scurfy phenotype and its human ortholog
EP0724644A4 (de) Für die untereinheiten der 1,3-beta-d-glucansynthase kodierende dna
DE60043062D1 (de) Gm-csf aus pferd
EP0643719A4 (de) Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen.
DE69619808T2 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
SE9602822D0 (sv) New receptor
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
ATE281519T1 (de) Klonierung und rekombinante herstellung des crf- rezeptors (crf=corticotropin ausloese faktor)
EP0860501A3 (de) Corticotropin freisetzende Rezeptoren des Faktor 2
SE9604439D0 (sv) New receptor

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings